Imodium Instant Melts (Loperamide Hydrochloride)

Loperamide acts on peripheral μ‑opioid receptors in the gut, reducing the release of acetylcholine and other neurotransmitters that stimulate muscle contraction. This slows peristalsis, allowing more water to be reabsorbed from the intestinal lumen, which results in firmer stools and fewer bowel movements.

The exact dose of Imodium Instant Melts is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of symptoms, and clinical condition. Patients should follow the prescriber’s instructions and the product labeling.

Safety data for loperamide in pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the medication.

To place an order, submit an enquiry on the Imodium Instant Melts product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Loperamide, the active ingredient in Imodium Instant Melts, is a peripheral μ‑opioid receptor agonist, whereas other OTC agents such as bismuth subsalicylate work by coating the gut and reducing inflammation. Loperamide generally provides faster symptom control by directly slowing motility, but it must be used with caution in infections that require antimicrobial therapy.

Store Imodium Instant Melts at ambient temperature, preferably below 25 °C (77 °F). Keep the films in their original packaging, protect them from moisture, direct sunlight and excessive heat to maintain product stability.

The product is an oral dissolving film that is placed on the tongue and allowed to dissolve completely without water. Once dissolved, the patient can swallow the resulting solution. Administration should follow the prescriber’s guidance and the instructions on the product label.

Serious risks include severe constipation that can lead to bowel obstruction, toxic megacolon, and cardiac arrhythmias, especially when high doses are taken or when combined with CYP3A4 or P‑glycoprotein inhibitors. Patients should seek immediate medical attention if they experience abdominal pain, bloating, or irregular heartbeats.

Imodium Instant Melts should be avoided in individuals with known hypersensitivity to loperamide, in cases of acute dysentery or colitis caused by invasive bacteria, and in patients with severe hepatic impairment without medical supervision. Children under two years of age should not use the product unless specifically directed by a healthcare professional.